Zymeworks Inc reports results for the quarter ended in March - Earnings Summary

Zymeworks

03/05/2024 21:13

* Zymeworks Inc  ZYME.OQ  reported a quarterly adjusted loss
of 42
cents​​ per share for the quarter ended in March, lower than the
same quarter last year, when the company reported EPS of -36
cents.  The mean expectation of seven analysts for the quarter
was for a loss of 29 cents per share. Wall Street expected
results to range from -42 cents to -13 cents per share.
    * Revenue fell 71.8% to $10.03 million from a year ago;
analysts
expected $17.43 million. 
    * Zymeworks Inc's reported EPS for the quarter was a loss
of 42
cents​.
    * The company reported a quarterly loss of $31.65 million.
    * Zymeworks Inc shares had fallen by 14.4% this quarter and
lost 13.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 26.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Zymeworks
Inc is
$14.60 

This summary was machine generated from LSEG data May 3 at 08:13
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.29          -0.42          Missed
 Dec. 31 2023      -0.43          -0.20          Beat
 Sep. 30 2023      -0.47          -0.41          Beat
 Jun. 30 2023      -0.47          -0.76          Missed